Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
Bupivacaine Hydrochloride Injection, USP ─ Solutions of bupivacaine hydrochloride that do not contain epinephrine may be autoclaved. Autoclave at 15-pound pressure, 121 °C (250 °F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration |
NDC 0409-1159-01 | 0.25% |
NDC 0409-1159-02 | 0.25% |
NDC 0409-1160-01 | 0.25% |
NDC 0409-1163-01 | 0.5% |
NDC 0409-1162-01 | 0.5% |
NDC 0409-1162-02 | 0.5% |
NDC 0409-1165-01 | 0.75% |
NDC 0409-1165-02 | 0.75% |
For single-dose vials: Discard unused portion.
Bupivacaine Hydrochloride and Epinephrine Injection, USP ─ Do not autoclave solutions of bupivacaine hydrochloride that contain epinephrine and protect from light. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration |
---|---|
NDC 0409-9042-01 | 0.25% |
NDC 0409-9042-17 | 0.25% |
NDC 0409-9043-01 | 0.25% |
NDC 0409-9045-01 | 0.5% |
NDC 0409-9045-17 | 0.5% |
NDC 0409-9046-01 | 0.5% |
For single-dose vials: Discard unused portion.
Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
Bupivacaine Hydrochloride Injection, USP ─ Solutions of bupivacaine hydrochloride that do not contain epinephrine may be autoclaved. Autoclave at 15-pound pressure, 121 °C (250 °F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration |
NDC 0409-1159-01 | 0.25% |
NDC 0409-1159-02 | 0.25% |
NDC 0409-1160-01 | 0.25% |
NDC 0409-1163-01 | 0.5% |
NDC 0409-1162-01 | 0.5% |
NDC 0409-1162-02 | 0.5% |
NDC 0409-1165-01 | 0.75% |
NDC 0409-1165-02 | 0.75% |
For single-dose vials: Discard unused portion.
Bupivacaine Hydrochloride and Epinephrine Injection, USP ─ Do not autoclave solutions of bupivacaine hydrochloride that contain epinephrine and protect from light. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration |
---|---|
NDC 0409-9042-01 | 0.25% |
NDC 0409-9042-17 | 0.25% |
NDC 0409-9043-01 | 0.25% |
NDC 0409-9045-01 | 0.5% |
NDC 0409-9045-17 | 0.5% |
NDC 0409-9046-01 | 0.5% |
For single-dose vials: Discard unused portion.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.